Anexon Reports $7 Million Venture Capital Investment
Thursday, October 21, 2010 5:34:00 AM PDT | VentureDeal Staff
Cambridge, Massachusetts -- Biotechnology company Anexon (no website) has secured $7 million in additional investment according to SEC regulatory filings.
Anexon is a very early stage company that is developing therapeutics for cardiovascular disease.
Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.
Email Page | Print Page